Silviculture

EQS-News: WashTec AG: 5.3% revenue growth in first nine months with significant 19.0% increase in EBIT

Retrieved on: 
Tuesday, November 7, 2023
Growth, Smartcar (company), Acquisition, Tax, Silviculture, EBIT

As a result of the revenue growth and active cost management, Group EBIT in the first nine months was €26.9m, significantly higher than in the prior year (€22.6m).

Key Points: 
  • As a result of the revenue growth and active cost management, Group EBIT in the first nine months was €26.9m, significantly higher than in the prior year (€22.6m).
  • The WashTec Group confirms the guidance for fiscal year 2023 and expects an increase in EBIT by around 10%.
  • “WashTec has completed the first nine months with record revenue and a significant increase in earnings.
  • The full Q3 2023 statement and further information about WashTec can be found on the WashTec: Investor Relations Website .

Custodian Property Income REIT plc: Second quarter trading update shows rental growth supporting fully covered dividends and stable values

Retrieved on: 
Tuesday, November 7, 2023
Achieved, International, Next, Lloyd, International Financial Reporting Standards, Jack Wills, Pride Park, LTV, Administration, REIT, ERV, Growth, Investment, WAULT, Aviva, Attitude, History, NAV, Community, EPRA, Movement, Shotley Bridge, Blue Cross, Holding company, Mineral wool, Renting, Security (finance), Lease, Commercial property, Silviculture, Rare-earth element, Bank, Halfords

The outcome for the NAV of Custodian Property Income REIT has been a marginal decrease of 3.9% over the past three quarters.

Key Points: 
  • The outcome for the NAV of Custodian Property Income REIT has been a marginal decrease of 3.9% over the past three quarters.
  • It is the strength of the occupational market driving rental growth and low vacancy that will ultimately support fully covered dividends and earnings growth.
  • Income/earnings remain a central focus for Custodian Property Income REIT, and it is income that will deliver positive total returns for shareholders.
  • The Board has approved an interim dividend per share of 1.375p for the Quarter, fully covered by EPRA earnings, payable on 30 November 2023.

Belite Bio Presents Results from a 24-month, Phase 2 Study of Tinlarebant in Childhood-onset Stargardt Disease at the AAO Annual Meeting

Retrieved on: 
Monday, November 6, 2023
Atrophy, Adolescence, Ageing, JAMA Ophthalmology, Principal investigator, Therapy, Natural history, Stargardt disease, Westmead, AAO, HIV disease progression rates, Baseline, Retrospective, DRAGON, Annual general meeting, University, Paratriathlon, Patient, Retina, FAF, Grade, SAN, Pharmaceutical industry, Silviculture, Ophthalmology

“Tinlarebant’s final Phase 2 results represent a significant milestone for Belite Bio and provide additional foundational support for the work being conducted across our trials,” said Dr. Tom Lin, Chairman and CEO of Belite Bio.

Key Points: 
  • “Tinlarebant’s final Phase 2 results represent a significant milestone for Belite Bio and provide additional foundational support for the work being conducted across our trials,” said Dr. Tom Lin, Chairman and CEO of Belite Bio.
  • “We are very encouraged by the promising 24-month treatment final results from this Phase 2 study.
  • The Natural History of the Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Studies: Design and Baseline Characteristics: ProgStar Report No.
  • Progression of Stargardt Disease as Determined by Fundus Autofluorescence in the Retrospective Progression of Stargardt Disease Study (ProgStar Report No.

In Historic Move, Medicare Proposes Preliminary Reimbursement Level for ReWalk Personal Exoskeleton

Retrieved on: 
Monday, November 6, 2023
FDA, HCPCS, Medicare, ReWalk, News, Light, Rehabilitation, Healthcare Common Procedure Coding System, Centers for Medicare & Medicaid Services, CMS, Health insurance, Silviculture

MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILLIT, Israel, Nov. 06, 2023 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”), a leading provider of innovative technologies that enable mobility and wellness in rehabilitation and daily life for individuals with neurological conditions, today announced that the Centers for Medicare & Medicaid Services (“CMS”) has included the ReWalk Personal Prosthetic Exoskeleton system in the agenda for the upcoming Healthcare Common Procedure Coding System (“HCPCS”) meeting on November 29, 2023 and provided a preliminary payment determination of $94,617.

Key Points: 
  • Preliminary payment determination of $94,617 does not yet factor in currently available ReWalk system with Breakthrough Device Designation.
  • CMS welcomes additional pricing materials at upcoming HCPCS meeting to reflect subsequent advancements in technology and pricing since ReWalk’s 2020 application.
  • In applying this formula to the code describing the ReWalk Personal Exoskeleton, CMS relied on average prices from 2020 market transactions, which CMS determined to be $125,500, and resulted in preliminary Medicare pricing of $94,617.
  • A final payment determination is expected in early 2024 with an April 1, 2024 effective date.

Osino Announces Positive Assay Results From Infill Drilling at Twin Hills Gold Project Including Best Hole to Date

Retrieved on: 
Wednesday, November 1, 2023
OSN, St. Michael's College School, Gold, GPS, Mining, UTM, UC, Technical, Selective, LUC, Geology, MRE, Bachelor of Science, News, Project, Exercise, National instrument, South African Council of Churches, Uniform, Honours degree, FSE, THC, National Instrument 43-101, SMU, OSI, NSX, GM, Coke (fuel), Clothing, Lobster, Telescopic sight, Silviculture, Oil, Tunnel, Uranium mining, Printed circuit board, Indication (medicine), Cloud, Bulge

VANCOUVER, British Columbia, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Osino Resources Corp. (TSXV:OSI) (NSX:OSN) (FSE:RSR1) (OTCQX:OSIIF) ("Osino” or “the Company”) is pleased to provide an update on the recently completed infill drill program at the Twin Hills Gold Project (“Twin Hills” or “the Project”) including the best hole drilled at the Project to date with an intercept of 61m at 3.21g/t. Osino remains focused on the financing and pre-construction activities at Twin Hills, as well as closely spaced infill drilling of the initial starter pits to validate modelling and de-risk initial production.

Key Points: 
  • 22m @ 1.80g/t
    Assay results from 50 out of 110 holes still to be reported with all results expected within 3 weeks.
  • Similar tightly spaced infill drilling at Clouds and Twin Hills Central pits is ongoing with the objective of converting the first 2 years of mining from Indicated to Measured mineral resource category across the Twin Hills project.
  • VANCOUVER, British Columbia, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Osino Resources Corp. (TSXV:OSI) (NSX:OSN) (FSE:RSR1) (OTCQX:OSIIF) ("Osino” or “the Company”) is pleased to provide an update on the recently completed infill drill program at the Twin Hills Gold Project (“Twin Hills” or “the Project”) including the best hole drilled at the Project to date with an intercept of 61m at 3.21g/t.
  • All holes drilled so far produced very good assay results as expected, with very consistent grades across the Twin Hills gold deposit.

Harmony Biosciences Reports Strong Third Quarter 2023 Financial Results

Retrieved on: 
Tuesday, October 31, 2023
IH, DM1, FDA, Research, Acquisition, Prader–Willi syndrome, Continue, Pivotal, LCA, Fragile X syndrome, Narcolepsy, FXS, Share repurchase, Conference, GAAP, Idiopathic hypersomnia, Bank statement, Development, Common stock, Commercialization, Growth, DSM-IV codes, Research and development, Benchmarking, PWS, Total, Myotonic dystrophy, Patient, Administration, Marketing, Shanda, Video game, Pharmaceutical industry, Fine chemical, Car rental, Silviculture, Cryptocurrency, Bank, Jean-François Zygel, Webcast, Harmony

ET

Key Points: 
  • ET
    PLYMOUTH MEETING, Pa., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Harmony Biosciences Holdings, Inc. (“Harmony” or the “Company”) (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients with rare neurological diseases, today reported financial results and business updates for the quarter ended September 30, 2023.
  • The average number of patients on WAKIX increased by approximately 350 sequentially to approximately 5,800 for the quarter ended September 30, 2023.
  • Reconciliations of applicable GAAP financial measures to Non-GAAP financial measures are included at the end of this press release.
  • ET
    We are hosting our third quarter 2023 financial results conference call and webcast today, beginning at 8:30 a.m. Eastern Time.

LIFT Intersects 18 m at 1.75% Li2O and 26 m at 1.02% Li2O at the BIG East pegmatite, Yellowknife Lithium Project, NWT

Retrieved on: 
Tuesday, October 31, 2023
Lithium, News, CSE, Echo, Silviculture, Asphalt, Road, Big

Drilling has intersected significant intervals of spodumene mineralization, with the following highlights:

Key Points: 
  • Drilling has intersected significant intervals of spodumene mineralization, with the following highlights:
    YLP-0109: 18 m at 1.75% Li2O, (BIG East)
    YLP-0068: 26 m at 1.02% Li2O, (BIG East)
    YLP-0066: 10 m at 1.40% Li2O, (BIG East)
    YLP-0067: 12 m at 1.08% Li2O, (Ki)
    YLP-0069: 10 m at 0.96% Li2O, (Ki)
    Francis MacDonald, CEO of LIFT comments, “We are pleased to see more very high-grade results coming from BIG East.
  • Last week we released holes YLP-0092 which intersected 18 metres at 1.79% Li2O which is located in the southwestern portion of the dyke system.
  • This week’s highlight of 18 metres at 1.75% Li2O in hole YLP-0109 is located in the northeastern portion of the dyke swarm, almost 500 metres away.
  • YLP-0066 was designed to test the BIG East swarm approximately 100 m from its northern end and 50 vertical metres beneath the surface.

Equillium Announces Data from Phase 1b EQUALISE Study Presented at the 2023 Annual Meeting of the American Society of Nephrology

Retrieved on: 
Monday, November 6, 2023
Oncology, Health, Clinical Trials, Pharmaceutical, Cardiology, Biotechnology, EOS, Type, EULAR, Patient, Standard of care, Lupus nephritis, Itolizumab, III, EGFR, Therapy, AMP, Children's Organ Transplant Association, CD6, Infection, Society, American Society of Nephrology, European Alliance of Associations for Rheumatology, European Renal Association, Dialysis, ASN, Partnership, MMF, ORR, ALC, S1P, Ono Pharmaceutical, Safety, Serum albumin, Proteinuria, Pharmaceutical industry, Silviculture, Nursing, Lupus, UPCR

“The presentation at ASN represents current data from the EQUALISE study, which includes all but the last patient in the follow up period,” said Bruce Steel, chief executive officer at Equillium.

Key Points: 
  • “The presentation at ASN represents current data from the EQUALISE study, which includes all but the last patient in the follow up period,” said Bruce Steel, chief executive officer at Equillium.
  • “We are encouraged that we continue to see clinically meaningful response rates, particularly in these highly proteinuric subjects.
  • Results are comparable to those observed in the Phase 3 AURORA1 study of voclosporin (ORR 70% at 6 and 12 months in active treatment).
  • Consistent with the decline in UPCR overtime, subjects were able to taper their systemic corticosteroids over the course of the study.

Used Jet Market Leads the Way in Overall Aircraft Inventory Gains

Retrieved on: 
Monday, November 6, 2023
Aircraft, EVI, Robinson, Sandhills Global, Acquisition, M/M, Aviation, YOY, Road Traffic Control Department, Jet fuel, Airline, Silviculture, Sandhills

Sandhills market reports track used turboprop and piston single aircraft in the U.S. as well as pre-owned jets and Robinson piston helicopters worldwide.

Key Points: 
  • Sandhills market reports track used turboprop and piston single aircraft in the U.S. as well as pre-owned jets and Robinson piston helicopters worldwide.
  • "This makes the aircraft market unique compared to the other markets and industries Sandhills monitors, where asking values have been dropping."
  • It describes and quantifies important trends in the buying and selling of used jet, piston single, turboprop, and Robinson piston helicopter aircraft.
  • Inventory levels in this market rose 17.24% M/M after several consecutive months of increases and were up 22.89% YOY in October.

Rising Inventories and Decreasing Values Persist for Used Heavy-Duty Trucks and Trailers

Retrieved on: 
Monday, November 6, 2023
EVI, M/M, Growth, YOY, Acquisition, Sandhills Global, Semi-trailer, Warehouse, Auction, Self storage, Silviculture, Sandhills

By contrast, the other markets have been weak, with current asking and auction values falling below year-ago levels.

Key Points: 
  • By contrast, the other markets have been weak, with current asking and auction values falling below year-ago levels.
  • The supply of used heavy-duty trucks in the U.S. has been rising for several months with inventory levels reaching a 46.71% year-over-year increase in October.
  • However, the market has not responded with strong demand for the abundance of used trucks, as illustrated by 18 months of consecutive declines in asking and auction values.
  • Asking and auction values were both lower in October than they were last year, reflecting a weak overall market for used heavy-duty trucks.